IAM Advisory’s AbbVie ABBV Stock Holding History

IAM Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$351K	Buy	1,394 +58	+4%	+$12.5K	0.07%	82
2026 Q1	$291K	Sell	1,336 -16	-1%	-$3.55K	0.07%	85
2025 Q4	$309K	Sell	1,352 -127	-9%	-$28.9K	0.07%	82
2025 Q3	$342K	Buy	1,479 +12	+0.8%	+$2.44K	0.08%	80
2025 Q2	$272K	Buy	1,467 +132	+10%	+$24.5K	0.07%	84
2025 Q1	$280K	Sell	1,335 -187	-12%	-$36.4K	0.07%	86
2024 Q4	$270K	Sell	1,522 -1	-0.1%	-$184	0.07%	88
2024 Q3	$301K	Buy	1,523 +12	+0.8%	+$2.24K	0.08%	84
2024 Q2	$259K	Sell	1,511 -15	-1%	-$2.48K	0.07%	88
2024 Q1	$278K	Buy	1,526 +38	+3%	+$6.55K	0.08%	86
2023 Q4	$231K	Buy	1,488 +3	+0.2%	+$437	0.07%	88
2023 Q3	$221K	Buy	+1,485	New	+$218K	0.08%	89

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

IAM Advisory's ABBV Position: Q2 2026 in Review

IAM Advisory increased its AbbVie (ABBV) stake by 4.3% in Q2 2026, buying an estimated $12.5K and bringing the position to 1,394 shares worth $351K. The position accounts for 0.07% of the portfolio, ranked #82.

IAM Advisory first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

IAM Advisory held 1,394 shares of AbbVie worth $351K as of Q2 2026.
IAM Advisory bought 58 AbbVie shares in Q2 2026, an estimated $12.5K.
AbbVie made up 0.07% of IAM Advisory's portfolio in Q2 2026, its #82 holding.
IAM Advisory first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on IAM Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.